Ip Share Discussion Threads

[seans66] 10/2/2015 17:21

All time high. You should not fall in love with a share but if IPO carries on like this, I shall make an exception!

[philo124] 04/2/2015 09:30

Nice move.

[skinwalker] 23/1/2015 08:54

Jeff/Justin
you've frightened everyone away with your podcast!
I think you can safely assume nobody here has much interest in the opinions of Zak Mir!

[jeffcranbounre] 31/12/2014 16:31

IP Group is mentioned in today's (31/12/14) ADVFN podcast

To listen to the podcast click here>

In today's podcast:

- Zak Mir PR at masterinvestor.co.uk and regular anchor on TipTV.co.uk chats about 3 stocks he thinks are worth checking out in 2015 - Zak's Twitter is @ZaksTradingCafe

- And the micro and macro news including:

Tesco #TSCO
GlaxoSmithKline #GSK
Tern #TERN
Bowleven #BLVN
Kibo Mining #KIBO
Nanoco #NANO
BP #BP.
Paternoster Resources #PRS
Man Group #EMG
DXS International
Lonmin #LMI
Praetorian Resources #PRAE
Castleton Technology #CTP
Sainsbury's #SBRY
Horizon Discovery #HZD
Asia Resource Minerals #ARMS
Jupiter Energy #JPR
Songbird Estates #SBD
London Stock Exchange #LSE
IP Group #IPO

Every Tuesday is Ten Bagger Tuesday on the podcast. If you know of a stock, whose share price has the potential to increase ten fold, just click the link below.



(All it involves is filling out a form that will take you around 5 minutes and you don't personally appear on the podcast).

Once a week, on a Friday, I feature a tip from a listener to this podcast, if you'd like to suggest a stock click the link below:



(Again all it involves is filling out a form that will take you around 5 minutes and you don't personally appear on the podcast).

You can subscribe to this podcast in iTunes by clicking

To follow me on Twitter click

As a listener to the ADVFN podcast you can take advantage of some exclusive first year discounts on popular subscriptions:

Bronze - £50 (normally £73.82/year)
Silver - £145 (normally £173.71/year)
Level 2 - £350 (normally £472.94/year)

Call 0207 0700 961 and ask for the ADVFN Podcast discount to take advantage of these reduced rates or just for more information.

Please DO NOT buy any stock recommended in this podcast basely solely on what you hear. The opinions in this podcasts are just that, opinions. Please do you own research before investing.

Justin

 

 

[backwoodsman] 22/12/2014 09:48

The Times front page story about NHS spending £300m (from memory) on sub-£1,000 fast DNA testing to transform and personalize treatments.

[skinwalker] 20/12/2014 21:17

No, I can't explain it, but all will become clear on monday 8.00am

[melody9999] 19/12/2014 19:23

Can anyone explain the share price action into the close today. All of a sudden buys at 231p and then a large UT trade at 227.9

[praipus] 18/12/2014 12:47

Been watching Jim Al-Khalili's "The Secrets of Quantum Physics"


He mentions the German industrialist's scramble to buy IP from Eddison for Light Bulbs so they could build and sell street lamps in the 1890's.

How reasonable is it to imagine history repeating itself and another such invention rising out of IP Groups portfolio?

[p1nkfish] 08/12/2014 09:08

Probably another chance for ALM. Waiting for that. Missed the chance too.

[philo124] 06/12/2014 20:09

Yep in SIPP; wish I had noticed ALM had got back to 260ish in the melt down a month or so ago.

[skinwalker] 06/12/2014 10:24

A good run at the moment - still a little too dependent on Oxford Nanopore I think, but I'm not selling!
Most of you know I expect - Allied Minds is a similar US concept. Early days but so far so good. I'm in!

[reels] 28/11/2014 13:18

Good coverage of Graphene opportunities on BBC. Should help portfolio value here. IMHO

[mickeyb] 27/11/2014 13:29

61.1% of £175m is £107.5m plus future royalties on top.

Market hasn't woken up to impact of this contract IP Group and more to come.

[philo124] 27/11/2014 08:04

Good reaction.

[broadwood] 27/11/2014 07:11

Very good news.

[broadwood] 26/11/2014 09:17

- IP Group portfolio company Genomics Ltd has completed a £10.3m fundraising. The funding came from new investors, including funds managed by Invesco Perpetual, Lansdowne Partners, Woodford Investment Management and the Wylie Family Trust, as well as existing shareholders including IP Group, one of its managed funds, and the University of Oxford. Following completion of the financing round, IP Group's undiluted beneficial stake of 16.7% in Genomics is valued at £4.3 million and IP Venture Fund II's 7.1% stake is valued at £1.8m. As a result of the Group's 33% limited partnership interest in IP Venture Fund II, its effective beneficial interest in Genomics is approximately 19%. The fundraising has resulted in an unrealised fair value gain to IP Group of £2.3 million and a fair value gain of £1.0m to IP Venture Fund II. IP Group and IP Venture Fund II committed £1.7 million and £0.7 million respectively to the fundraising. Genomics, a spin-out from the University of Oxford, has developed an analytical platform for genomic sequence data analysis -

[broadwood] 20/11/2014 09:12

- IP Group says it is 'delighted to note' that Modern Biosciences has been awarded a grant of up to £2.4m by the UK Government-backed Biomedical Catalyst. The award will provide support for Modern Biosciences' lead programme for the development of novel bone-protective compounds in the treatment of rheumatoid arthritis ("RA"). RA is a severe, crippling inflammatory disease which causes progressive joint and bone erosion and eventual disability. MBS' compounds act by an entirely novel mechanism of action to target both the inflammatory component of RA and its associated bone destruction. This has the potential to not only protect the joints of RA sufferers from further damage but to reverse existing damage. Modern Biosciences was established to source late-stage discovery projects from academia, conduct early proof-of-principle clinical studies and out-license the resulting programmes to the pharmaceutical industry. IP Group holds an undiluted beneficial interest of 61.1% in Modern Biosciences and, as a result, its income and expenses are consolidated into those of the group. -

[broadwood] 13/11/2014 07:23

IP Group well placed for future growth

[anley] 16/10/2014 17:16

The price drop is the MM covering their positions after the shock of some US Hedge Funds loosing $billions on the pulled merger - Shire etc......that is my view.

[seans66] 15/10/2014 23:10

Think you spoke too soon...

[mickeyb] 15/10/2014 09:31

Sp looks like it is starting the next upward phase, very encouraging.